Dr. Ching is Assistant Professor and one of the directors of the Metabolomics Research facility at Duke-NUS Medical School (Metabolomics @Duke-NUS). His research focuses on profiling small-molecules and products of metabolism. He has pioneered the first metabolomics service facility in Singapore in 2012, analysing intermediates of the central carbon metabolism. Dr Ching has orchestrated multiple large cohort clinical metabolomics studies, and participated in multi-disciplinary research such as cancer, cardiovascular disease and neuro-related disorders. His facility had since expanded with state-of-the-art equipment such as the orbitrap, liquid chromatography and gas chromatography-triple quadruple mass spectrometers and an ion chromatography mass spectrometer.


Dr Ching’s primary research lies in the development of analytical methodologies for metabolites testing, such as glycolytic intermediates, volatile organic compounds, fatty acids and a global metabolite screening platform. He has a special interest in diabetes and diabetic kidney diseases. His recent research focuses on stable isotope tracing of acylcarnitine biomarkers discovered from diabetic kidney disease patients.